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Background: Centipede grass (CG) originates from China and South America and is reported to contain several
C-glycosyl flavones and phenolic constituents, including maysin and luteolin derivatives. This study aimed to
investigate, for the first time, the antiobesity activity of CG and its potential molecular mechanism in 3T3-L1 cells.
Methods: To study the effect of CG on adipogenesis, differentiating 3T3-L1 cells were treated every day with CG
at various concentrations (0–100 μg/ml) for six days. Oil-red O staining and triglyceride content assay were performed
to determine the lipid accumulation in 3T3-L1 cells. The expression of mRNAs or proteins associated with
adipogenesis was measured using RT-PCR and Western blotting analysis. We examined the effect of CG on level of
phosphorylated Akt in 3T3-L1 cells treated with CG at various concentration s during adipocyte differentiation.
Results: Differentiation was investigated with an Oil-red O staining assay using CG-treated 3T3-L1 adipocytes. We
found that CG suppressed lipid droplet formation and adipocyte differentiation in 3T3-L1 cells in a dose-dependent
manner. Treatment of the 3T3-L1 adipocytes with CG resulted in an attenuation of the expression of
adipogenesis-related factors and lipid metabolic genes. The expression of C/EBPα and PPARγ, the central
transcriptional regulators of adipogenesis, was decreased by the treatment with CG. The expression of genes involved
in lipid metabolism, aP2 were significantly inhibited following the CG treatment. Moreover, the CG treatment
down-regulated the phosphorylation levels of Akt and GSK3β.
Conclusions: Taken collectively, these data indicated that CG exerts antiadipogenic activity by inhibiting the
expression of C/EBPβ, C/EBPα, and PPARγ and the Akt signaling pathway in 3T3-L1 adipocytes.Background
Obesity is an important issue in the field of preventive
medicine and public health because it is considered to
be a risk factor associated with the development of mul-
tiple diseases, including heart disease, hypertension, and
diabetes [1]. Recently, obesity has become the leading
metabolic disease and is a significant problem owing to* Correspondence: jaehcho@gsnu.ac.kr
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reproduction in any medium, provided the orthe increased risk of premature death. Adipocytes play a
critical role in regulating lipid metabolism and energy
balance and are associated with adipose tissue mass and
obesity. Indeed, obesity is induced by the hypertrophy of
adipocytes and the generation of new adipocytes from
precursor cells [2]. As lipid accumulation reflects the
process of adipogenesis and the programmed differen-
tiation of preadipocytes involves several stages related to
obesity [3], many studies have aimed to reduce obesity by
focusing on decreasing preadipocyte differentiation and
proliferation, inhibiting lipogenesis, and increasing lipolysis.
Adipocyte differentiation is a complex process that is
regulated by various transcription factors and adipogenesis-. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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several transcriptional factors, CCAAT/enhancer binding
protein-β (C/EBPβ), peroxisome proliferator-activated
receptor-γ (PPARγ) and CCAAT/enhancer binding
protein-α (C/EBPα) [4]. C/EBPβ is expressed in the early
stage of adipocyte differentiation and activates the tran-
scription of C/EBPα and PPARγ, transcription factors
that activate the expression of the adipocyte genes that
give rise to the adipocyte phenotype [4,5]. The expression
of C/EBPα and PPARγ is also associated with terminal
differentiation, and these factors act in concert to
generate fully mature adipocytes by their subsequent
transactivation of adipocyte-specific genes [6]. During
adipogenesis, PPARγ and C/EBPα activate the expression
of lipid-metabolizing enzymes, such as fatty acid binding
protein 4 (aP2), lipoprotein lipase (LPL), and fatty acid
synthetase (FAS) [6,7].
The serine/threonine kinase Akt plays an essential role
in adipocyte differentiation. Mouse embryonic fibroblasts
lacking Akt have impaired ability to differentiate into
mature adipocytes [8], and an RNAi-mediated decrease
of Akt is found to block the differentiation of 3T3-L1
cells [9]. Moreover, the overexpression of constitutively
active Akt results in increased glucose uptake and adipo-
cyte differentiation in 3T3-L1 adipocytes [9]. Akt phos-
phorylates and regulates a large number of substrates
involved in a diverse array of biological process [10], and
it is essential for the induction of PPARγ expression
[11]. GSK3β is a critical downstream signaling protein
for the phosphoinositide 3-kinase (PI3K)/Akt pathway.
Insulin signaling activates Akt through PI3K and induces
serine/threonine phosphorylation of the downstream
target, GSK3β, which phosphorylates C/EBPβ, C/EBPα,
and glycogen synthase (GS) [12,13].
Centipede grass (CG) (Eremochloa ophiuroides) is na-
tive to China and Southeast Asia, and it is now one of
the most popular lawn grasses in South America [14].
Wiseman et al. showed that CG has a several C-glycosyl
flavones and phenolic constituents [15], and a recent
study has reported that the methanolic extracts from the
leaves of CG exhibited an inhibitory effect against pan-
creatic lipase [16].
In the present study, the effect of CG on the adipocyte
differentiation of 3T3-L1 cells was investigated by meas-
uring lipid accumulation and the expression levels of
adipocyte marker genes and their target genes. More-
over, to understand the specific mechanisms of these
effects, we examined whether Akt and GSK3β activation
are critical for the anti-adipogenic functions of CG.
Methods
Preparation of centipede grass
The extract of Centipede grass (CG) (Eremochloa ophiur-
oides) was supplied by Korea Atomic Energy Institute(KAERI). CG extract contains Luteolin-6-C-boivinopyra-
noside, orientin, isoorientin, derhamnosylmaysin, isoorien-
tin 2-O-α-L-rhamnoside, and luteolin and the extraction
procedure was previously described [16].
Cell viability and cytotoxicity
The cytotoxic effects of CG, and its effects on cell viabi-
lity, were determined in LDH and MTT assays. Cells
were seeded at a density of 1 x 105 cells/well into 24 well
plates. After 24 h, they were treated with CG for 4 day
or 6 day. MTT was added to each well, and the plates
incubated for 4 h at 37°C. The liquid in the plate was
removed, and dimethyl sulfoxide (DMSO) added to di-
ssolve the MTT-formazan complex formed. The optical
density was measured at 540 nm. The effect of CG on
cell viability was evaluated as absorbance relative to that
of control cultures. The cytotoxicity effect of CG was
measured using an LDH cytotoxicity detection kit
(Roche Applied Science, USA). LDH activity was mea-
sured, according to the manufacturer’s protocol, in culture
supernatants and cell lysates to evaluate cytotoxicity.
Cell culture and differentiation
Mouse 3T3-L1 preadipocytes were grown in Dulbecco’s
modified eagle medium (DMEM) high glucose with 10%
calf serum at 37°C in a humidified atmosphere of 5% CO2.
After 3T3-L1 cells reached confluency, the cells were incu-
bated in differentiation/induction medium (DMII) contain-
ing 167 nM insulin, 0.5 mM 3-isobutyl-1-methylxanthine,
100 μM indomethacin, and 0.25 μM dexamethasone in
DMEM containing 10% FBS. The differentiation/induction
medium was changed every 2 days. To examine the effects
of CG on the differentiation of preadipocytes to adipo-
cytes, cells were cultured in DMII differentiation medium
in the presence of various concentrations (10 μg/ml or
100 μg/ml) of centipede grass. The differentiated cells were
used after 4 or 6 days of initiating the differentiation.
Oil-red O staining
After the induction of differentiation, cells were stained
with Oil-red O. Cells were treated either with CG
extracts (10 μg/ml or 100 μg/ml) or vehicle in the differ-
entiation medium for day 0–6 of adipogenesis. On day 4
or 6, cells were stained with Oil-red O. For Oil-red O
staining, cells were washed gently with PBS, and stained
with filtered Oil-red O solution for 30min. After staining
the lipid droplets red, the Oil-red O staining solution
was removed and the plates were rinsed with water and
dried. The stained lipid droplets were viewed on an
Olympus microscope (Tokyo, Japan).
Triglyceride content assay
Cellular triglyceride contents were measured using a
commercial triglyceride assay kit (Sigma-Aldrich, MO,
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pocytes differentiated for 4 or 6 days were treated with
the CG at concentrations of 0, 10 and 100 μg/ml in
6-well plates. To analyze the content of cellular triglyce-
rides, cells were washed with PBS and then scraped into
200 μl PBS and homogenized by sonication for 1min.
The lysates were assayed for total triglycerides by using
the assay kits.
RNA preparation and RT-PCR
Cellular RNA was isolated from 3T3-L1 adipocytes using
Trizol reagent (Invitrogen, USA) according to the manufac-
turer’s instructions. One microgram of total RNA was
subjected to first strand cDNA synthesis with oligo (deo-
xythymidine) primers and Superscript II reverse trans-
criptase (invitrogen, CA, USA). Gene expression was
normalized using β-actin as a reference gene. Data were
analyzed using Opticon Monitor software (Bio-Rad). The
target cDNA was amplified using the following sense and
antisense primers: sense 5′-GACTACGCAACACACGTG
TAACT-3′ and antisense 5′-CAAAACCAAAAACATCAA
CAACCC-3′ for C/EBPβ; sense 5′-TTT-TCA-AGG-GTG
CCA-GTT-TC-3′ and antisense 5′-AAT-CCT-TGG-CCC
TCT-GAG-AT-3′ for PPARγ; sense 5′-TGA-AGA-GGT
CGG-CGA-AGA-GTT-CG-3′ and antisense 5′-GGC-GGT-
CAT-TGT-CAC-TGG-TCA-AC-30 for C/EBPα; Control
detection of β-actin was performed with sense
(5′- GACAACGGCTCCGGCATGTGCAAAG-3′) and anti-
sense (5′-TTCACGGTTGGCCTTAGGGTTCAG-3′) pri-
mers under the same conditions.
Western blot analysis
Western blotting was performed according to standard
procedures. Briefly, cells were washed with ice-cold
PBS, and lysed in lysis buffer (50 mM Tris–HCl
(pH 8.0), 0.4% Nonidet P-40, 120 mM NaCl, 1.5 mM
MgCl2, 0.1% SDS, 2 mM phenylmethylsulfonyl fluor-
ide, 80 μg/ml leupeptin, 3 mM NaF and 1 mM DTT).
After cell debris was removed by centrifugation, lysate
protein concentrations were determined using Bio-Rad
protein Assay Reagent (Bio-Rad Laboratories, USA).
Cell lysates were then subjected to electrophoresis on
10-15% SDS-polyacrylamide gels containing SDS, and
transferred onto a polyvinylidene fluoride membrane
(Amersham Pharmacia, UK). PPARγ, C/EBPβ, C/EBPα,
aP2, Akt, and GSK3β antibody were from cell signaling and
the monoclonal β-actin antibody was from Chemicon.
HRP-labeled mouse anti-rabbit IgG were from Jackson
ImmunoResearch. The Chemiluminescence kit was from
Pierce (Rockford, IL). After incubation with horseradish-
peroxidase-conjugated secondary antibody at room
temperature, immunoreactive proteins were detected using
a chemiluminescent ECL assay kit (Amersham Pharmacia,
UK) according to the manufacturer’s instructions.Statistical analysis
Data are expressed as means ± SD. Comparison between
groups made by ANOVA variance analysis, and significant
was analyzed by Ducan’s multiple range tests. Differences
of p < 0.05 were considered to be statistically significant.
Results
Effect of CG on the adipocyte differentiation of 3T3-L1
preadipocytes
The 3T3-L1 cells line, derived from mouse embryo fibro-
blasts, has been used as a model of adipogenic differen-
tiation and insulin action. During differentiation, the cells
undergo growth arrest and initiate differentiation that is
manifested by gene expression and the morphological
characteristics of mature adipocytes, such as the accumu-
lation of lipid droplets. To assess any cytotoxic effects of
CG, cell viability and cytotoxicity in 3T3-L1 adipocytes
were evaluated using MTT and LDH assays. The 3T3-L1
cells were treated with different concentrations of CG
(0, 10, or 100 μg/ml) with a DMII mixture for 4 or 6 days.
At a concentration of 100 μg/ml, CG had no significant
inhibitory effects on cell viability and did not cause cyto-
toxicity in the 3T3-L1 cells after 4 or 6 days of incubation,
as determined by the MTT and LDH assays (Figure 1A, B).
The 3T3-L1 preadipocytes were also treated at various con-
centrations (100, 200, and 300 μg/ml) for 6 days without
differentiation, and CG did not show any cytotoxicity at up
200 μg/ml. Next, to determine the potential inhibitory
effects of CG extracts on adipocyte differentiation, 3T3-L1
preadipocytes were differentiated in DMII alone or with
DMII and CG (0, 10, or 100 μg/ml) during adipocyte differ-
entiation for 6 days. The 3T3-L1 cells were fully differen-
tiated by 6 days, and the accumulation of lipids was
visualized with a microscopic inspection and Oil-red O
staining. The treatment of CG resulted in a strong reduc-
tion of the lipid droplets in a dose-dependent manner in
the 3T3-L1 adipocytes (Figure 1C). The cells treated with
the DMII mixture plus 100 μg/ml of CG extract accumu-
lated 65% of the intracellular triglyceride level contained in
the DMII mixture-treated positive controls, as shown by
the Oil-red O staining (Figure 1C). These results indicated
that CG (100 μg/ml) inhibited lipid accumulation without
exerting cytotoxicity during 3T3-L1 differentiation under
DMII culture conditions. Next, to investigate the effect of
CG on adipocyte differentiation, 3T3-L1 cells were treated
with various concentrations of CG in the presence of
DMII. As a major marker of adipogenesis, lipid accumula-
tion was quantified by measuring the triglyceride content
during 3T3-L1 differentiation. The triglyceride content of
the cells increased during the 3T3-L1 differentiation for 6
days, and the addition of CG into the differentiation
medium completely blocked the triglyceride accumulation
(Figure 1D). The inhibitory effects of CG on the trigly-
ceride accumulation during adipocyte differentiation were
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Figure 1 (See legend on next page).
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Figure 1 Effect of Centipede grass on 3T3-L1 preadipocyte differentiation. 3T3-L1 preadipocytes were induced to differentiate as described
in Materials and Methods. At day 4 or 6, cell viability and cytotoxicity were assessed in MTT and LDH assays. (A) 3T3-L1 preadipocytes was
incubated with DMII media for 4 or 6 days and treated with different concentration of CG every day. Con, 3T3-L1 preadipocytes; DMII, fully
differentiated adipocytes (0.5 mM 3-isobutyl-1-methylxanthine, 100 μM indomethason, 0.25 μM dexamethasone and 167 nM insulin); 10 μg/ml,
fully differentiated adipocytes (DMII + 10 μg/ml CG); 100 μg/ml, fully differentiated adipocytes (DMII + 100 μg/ml CG). Cell viability was
determined by MTT assay. Results represent the mean ± SD of three independent experiments. (B) LDH assay was performed to determine
cytotoxicity during differentiation. Results represent the mean ± SD of three independent experiments. (C) 3T3-L1 preadipocytes were
differentiated into adipocytes in DMII medium contained with or without different concentration of CG for 6 days. On day 6, cells were stained
with Oil-red O to visualize lipid accumulation. (D) CG reduced TG content during differentiation of 3T3-L1 cells. 3T3-L1 preadipocytes were
differentiated in the absence or presence of CG for 4 or 6 days, and the lipid accumulation was measured by triglyceride assay. Data are
mean ± SD values of at least three independent experiments. (*) p < 0.05, (**) P < 0.01 compared with the differentiated adipocytes (DMII).
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cated that CG exerts antiadipogenic activity in 3T3-L1
adipocytes.
Effect of CG on the expression of adipogenic-specific
genes during adipocyte differentiation
Next, we investigated the influence of CG on the expre-
ssion of several adipogenic genes. To determine whether
the reduced accumulation of intracellular lipid droplets
resulted from a CG extract-mediated alteration in the
3T3-L1 differentiation, the expression of the adipogenic-
specific genes, C/EBPβ, PPARγ, and C/EBPα, were exa-
mined in the cells cultured in the presence or absence of
CG (10 or 100 μg/ml) with adipogenic stimulation for 4
or 6 days. Our RT-PCR analysis revealed that the ex-
pression of C/EBPβ, C/EBPα, and PPARγ mRNA was
induced in the adipocytes when the 3T3-L1 cells had
become fully differentiated, whereas the expression
of these genes was significantly decreased by CG
(Figure 2A). CG treatment at 10 μg/ml or 100 μg/ml
decreased the expression of C/EBPα mRNA by 28% or
59%, respectively, in the fully differentiated adipocytes,
and the expression of PPARγ mRNA was decreased by
approximately 21% or 55% compared to the fully diffe-
rentiated cells (Figure 2A). To determine the protein
expression patterns of adipogenic-specific genes during
3T3-L1 differentiation, we performed western blot ana-
lyses using antibodies against C/EBPβ, C/EBPα, and
PPARγ. When CG was added with the DMII medium to
the 3T3-L1 adipocytes, the expression of C/EBPβ, an
early phase adipogenic transcription factor, was su-
ppressed compared to the positive control cells, which
were incubated with DMII only. We also determined the
expression level of PPARγ and C/EBPα, which regulate
adipogenesis and strictly associated with the initial
appearance of lipid droplets during 3T3-L1 differen-
tiation, respectively. Our results showed that the DMII
mixture markedly increased the expression of C/EBPα
and PPARγ, whereas the addition of CG to the 3T3-L1
cells significantly decreased the expression of C/EBPα
and PPARγ protein at day 4 during the late stages of adi-
pocyte differentiation (Figure 2B and C). To investigatewhether the attenuated expression of PPARγ and
C/EBPα further affected the activation of their target
gene, aP2, we investigated the expression of aP2 under
the same conditions. Treatment with CG significantly
down-regulated aP2 expression compared to the fully
differentiated 3T3-L1 adipocytes (Figure 2B and C).
Effect of CG on the Akt pathway
To investigate the effect of CG on the regulation of the
Akt pathway, we examined whether CG changed the
phosphorylation levels of the downstream molecules of
insulin signaling. The 3T3-L1 cells were treated with
various concentrations of CG (0, 10, or 100 μg/ml) du-
ring differentiation, and, on day 4 or 6, the level of ex-
pression and phosphorylation of Akt and its substrate,
GSK3β, a well-established cellular indicator of Akt acti-
vation, were examined. Lysates were collected and
immunoblotted with phospho-independent Akt or
GSK3β antibodies, phospho-Thr473 Akt (which recog-
nizes Akt when Thr471 is phosphorylated), and
phospho-Ser9 GSK3β (which recognizes GSK3β when
Ser9 is phosphorylated). In the presence of DMII, the
level of Akt phosphorylation (Thr-473) was highly
increased, whereas treatment with CG decreased the
level of the phosphorylated form of Akt (Figure 3A). The
phosphorylation of GSK3β under the DMII mixture
resulted in a robust increase in phospho-Ser9 immuno-
reactivity. In contrast to these findings, the treatment of
3T3-L1 adipocytes with 100 μg/ml CG resulted in a
large decrease in the phosphorylation level of GSK3β
(Figure 3B). These results demonstrated that CG treat-
ment markedly inhibited the phosphorylation of Akt and
GSK3β, leading to the inhibition of adipocyte differen-
tiation by suppressing the Akt pathway.
Discussion
Centipede grass has several C-glycosyl flavones, lueteolin
6-C-beta-D-boivinopyranoside and mayosin, which func-
tions as a pancreatic lipase inhibitor [16]. In the present
study, we carried out experiments aimed at determining
the mechanism of the antiobesity activity of CG. The
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Figure 2 Effect of CG on expression of adipogenesis-related
genes. 3T3-L1 preadipocytes were differentiated into adipocytes in
DMII medium with the absence or presence of 10 μg/ml or
100 μg/ml CG for 4 or 6 days. Con, 3T3-L1 preadipocytes; DMII,
fully differentiated adipocytes (0.5 mM 3-isobutyl-1-methylxanthine,
100 μM indomethason, 0.25 μM dexamethasone and 167 nM
insulin); 10 μg/ml, fully differentiated adipocytes (DMII + 10 μg/ml
CG); 100 μg/ml, fully differentiated adipocytes (DMII + 100 μg/ml
CG). (A) CG inhibited the expression of adipocyte-specific
transcription factors during differentiation. The gene expression was
performed by RT-PCR and all gene expression was normalized using
β-actin as reference gene. All experiments were performed in three
independent experiments. (*) p < 0.05, (**) P < 0.01, (***) P < 0.001
versus the control (DMII) group at each gene expression. (B) CG
attenuated the expression of adipogenesis-related genes in 3T3-L1
adipocytes. Total cell lysates were isolated from 3T3-L1 adipocytes at
day 4 or day 6 after induction of differentiation. Immunoblotting
analysis was performed as described in Methods. (C) The relative
expression of adipogenesis-related genes after treating CG for 4 or
6 days. All gene expressions were normalized using β-actin as a
reference gene. The data shown are representative of three
independent experiments. (*) p < 0.05, (**) P < 0.01, (***) P < 0.001
versus the control (DMII) group at each gene expression.
Park et al. BMC Complementary and Alternative Medicine 2012, 12:230 Page 6 of 9
http://www.biomedcentral.com/1472-6882/12/230their differentiation in a dose-dependent manner. CG
treatment prevented the adipocyte differentiation by sup-
pressing Akt activity, which sequentially attenuated the ex-
pression of C/EBPβ, C/EBPα, and PPARγ, key adipogenic
transcription factors. The expression of aP2, terminal dif-
ferentiation marker of adipocytes, was significantly inhib-
ited by the treatment with CG.
It has been demonstrated that adipocyte differentiation
and fat accumulation are associated with the develop-
ment of obesity [2]. Increase in the adipocyte number
and mass results from the massive adipocyte differenti-
ation process, which generates mature adipocytes from
preadipocytes [3]. One of the best-characterized and
widely used in vitro models to study adipocyte differen-
tiation has been the 3T3-L1 preadipocyte cell line, which
is committed to the adipocytic lineage and to adipocyte
differentiation via intracellular fat droplet accumulation
[17]. In the present study, our results demonstrated that
the treatment of 3T3-L1 preadipocytes with CG inhi-
bited their differentiation in a dose-dependent manner.
CG extract (100 μg/ml) did not cause apparent cytoto-
xicity in both the undifferentiated or differentiated 3T3-
L1 cells. Moreover, the accumulation of lipid droplets in
the 3T3-L1 adipocytes was largely reduced by treatment
with CG compared with the untreated differentiated
cells, and the inhibitory effect was dose dependent. This
result is supported by the quantitative analysis of the intra-
cellular lipid content, which revealed that the cells under
treatment with 100 μg/ml CG showed 60% reductions in
the triglyceride levels in differentiated cells after 6 days,
suggesting that CG led to the strong inhibition of adipo-







Con    DMII   10µg/ml 100µg/ml
CG







































DMII DMII + 100µg/ml CG DMII                 DMII + 100µg/ml CG




























Con    DMII   10µg/ml 100µg/ml
CG
Con     DMII    10µg/ml 100µg/ml
DMII                   DMII + 100µg/ml CG DMII                     DMII + 100µg/ml CG

































































Figure 3 Effect of CG on phosophorylation of Akt and GSK3β during 3T3-L1 differentiation. 3T3-L1 preadipocytes were differentiated in
the absence or in the presence of CG for 4 or 6 days. (A, B) 3T3-L1 adipocytes were treated with CG for indicated concentration and
phosphorylation levels for Akt and GSK3β were determined by Western blotting analysis. The extent of phosphorylation was calculated by
determining the amount of phosphorylated Akt relative to total Akt levels (DMII or DMII + 100 μg/ml CG). Data are mean ± SD values of at least
three independent experiments. (*) p < 0.05, (**) P < 0.01.
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in adipocytes, and the insulin-stimulated phosphorylation
of Akt plays critical roles in insulin-induced glucose metab-
olism, glucose transport, and adipocyte differentiation [8,9].
The overexpression of Akt results in increased glucose up-
take and adipocyte differentiation, and the inhibition of Akt
expression blocked adipocyte differentiation in 3T3-L1 pre-
adipocytes [18]. In the present study, our results demon-
strated that CG significantly decreased the phosphorylationof Akt in a concentration-dependent manner in 3T3-L1
adipocytes.
Preadipocyte differentiation is controlled by a subtle bal-
ance of serial and interdependent transcription factors [6].
C/EBPδ and C/EBPβ are rapidly and transiently expressed
during the early stages of adipocyte differentiation, prior
to the transcriptional activation of adipocyte-specific
genes [19]. These genes act synergistically to induce the
expression of C/EBPα and PPARγ, which promotes the
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ration and differentiation [19]. Therefore, we investigated
whether decreased Akt and GSK3β phosphorylation
induced the decreased expression of adipogenic genes,
such as C/EBP and PPARγ. Our results showed that the
CG treatment strongly inhibited the expression of C/EBPβ
in a dose-dependent manner in 3T3-L1 adipocytes and
that the inhibition of adipocyte differentiation by CG cor-
relates with the inhibition of C/EBPβ expression, which
plays a critical role in adipocyte differentiation. Moreover,
our data showed that CG significantly attenuated the
expression of PPARγ and C/EBPα compared to DMII-
induced adipocytes, indicating that CG inhibited adipo-
genesis in the 3T3-L1 cells by down-regulating PPARγ
and C/EBPα expression.
More interestingly, the insulin signaling pathway acti-
vates Akt and induces the serine/threonine phosphory-
lation of the downstream target, GSK3β. Akt appears to
participate in the insulin signaling pathway through the
phosphorylation of GSK3β and by stimulating GLUT4
translocation [20]. Our data showed that after treatment
with CG, the 3T3-L1 adipocytes exhibited marked
decreases in the phosphorylation level of GSK3β (Ser-9),
suggesting that the decreased phosphorylation of GSK3β
at Ser-9 could lead to increased phosphorylation of its cor-
responding substrates. GSK3β is a ubiquitously expressed
serine/threonine protein kinase and had been reported as
the C/EBPβ or C/EBPα kinase [13,21]. The insulin-
induced dephosphorylation of C/EBPα involved the inacti-
vation of GSK3β, and treatment with the GSK3β inhibitor,
lithium, prevented the differentiation of 3T3-L1 preadipo-
cytes into adipocytes [13]. Shim et al. showed that the
GSK3β-mediated phosphorylation of C/EBPα targets it for
proteasomal degradation [22], and another study also
demonstrated that the Fbxw7-dependent degradation of
C/EBPα was dependent on the phosphorylation of Thr222
and Thr226, which are GSK3β phosphorylation sites [23].
Furthermore, the Akt signaling cascade is considered im-
portant for adipogenesis, as it appears to activate PPARγ
and C/EBPα during the induction of 3T3-L1 adipocyte
differentiation [24]. Xu et al. showed that the expression
of Akt induces an important association between the
PI3-kinase-PKB/Akt signal cascade and the transcription
factors PPARγ and C/EBPα in the induction of 3T3-L1
adipocyte differentiation [9]. Taken together, our results
revealed that the suppression of adipogenesis by CG was
caused by the decreased levels of C/EBPβ, C/EBPα, and
PPARγ expression through the attenuation of Akt and
GSK3β phosphorylation.
The expression of C/EBPα and PPARγ synergistically
induces terminal differentiation by transactivating the
expression of downstream adipocyte-specific gene, aP2,
which is gene involved in the maturation of adipocytes.
Therefore, the effect of CG on the expression of aP2 wasinvestigated during 3T3-L1 differentiation. Under diffe-
rentiation conditions, the expression of aP2 was signifi-
cantly decreased by CG treatment. Together, our results
demonstrated that CG strongly suppressed the expre-
ssion of critical genes involved in creating and maintai-
ning the adipocyte phenotype and reduced lipid storage
and accumulation in 3T3-L1 adipocytes.
Conclusions
In the present study, we demonstrated that CG inhibited
adipocyte differentiation and adipogenesis in 3T3-L1
adipocytes. Our results revealed that CG inhibited adi-
pocyte differentiation by suppressing Akt and GSK3β
phosphorylation and their activities, leading to the
attenuation of the expression of C/EBPβ, C/EBPα, and
PPARγ. Moreover, we showed that CG treatment also
decreased the level of aP2 and reduced the lipid accu-
mulation in 3T3-L1 cells. Collectively, these findings
provide strong evidence that CG might inhibit adipoge-
nesis through the Akt pathway in 3T3-L1 adipocytes.
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